Adrenomedullin: A Multifunctional Peptide Involved in Blood Pressure, Growth, Hormones, and Disease

Adrenomedullin is a multifunctional regulatory peptide affecting vasodilation, cell growth, hormone secretion, inflammation, and kidney function, with therapeutic potential in cardiovascular and inflammatory diseases.

López, José et al.·International review of cytology·2002·Moderate EvidenceReview
RPEP-00749ReviewModerate Evidence2002RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Adrenomedullin functions as a vasodilator, growth regulator, neurotransmitter, anti-inflammatory agent, and hormone modulator through CRLR/RAMP receptor complexes, with therapeutic implications across cardiovascular, inflammatory, and neoplastic diseases.

Key Numbers

How They Did This

Comprehensive review of adrenomedullin cell and molecular biology covering receptor characterization, signaling pathways, tissue expression, and diverse biological functions.

Why This Research Matters

Understanding ADM's full functional range is essential for developing therapeutics that harness its beneficial effects while managing its diverse actions across organ systems.

The Bigger Picture

Adrenomedullin exemplifies how a single peptide can serve as a master regulator across multiple physiological systems — similar to how ghrelin coordinates metabolism.

What This Study Doesn't Tell Us

Review of ADM's expanding biology; therapeutic translation was still largely conceptual at the time.

Questions This Raises

  • ?Can specific ADM functions be targeted independently?
  • ?Which ADM application has the greatest therapeutic potential?
  • ?Could ADM receptor-selective drugs avoid unwanted multi-system effects?

Trust & Context

Key Stat:
6+ functions One peptide regulates vasodilation, growth, neurotransmission, inflammation, hormones, AND electrolytes — ADM is a master multi-system regulator
Evidence Grade:
Moderate evidence from a comprehensive molecular biology review integrating receptor, signaling, and functional data.
Study Age:
Published in 2002. ADM biology has been further characterized, with ADM-targeting drugs in clinical development for sepsis.
Original Title:
Cell and molecular biology of the multifunctional peptide, adrenomedullin.
Published In:
International review of cytology, 221, 1-92 (2002)
Database ID:
RPEP-00749

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What does adrenomedullin do?

Almost everything. It relaxes blood vessels, regulates cell growth, transmits nerve signals, fights inflammation, modulates hormones, and controls electrolyte balance. Its diversity of functions makes it both a therapeutic opportunity and a complexity challenge.

Is it being developed as a drug?

ADM itself and drugs targeting its receptors (CRLR/RAMP) are being developed for sepsis and cardiovascular disease. The biomarker MR-proADM is already used clinically for sepsis risk assessment.

Read More on RethinkPeptides

Cite This Study

RPEP-00749·https://rethinkpeptides.com/research/RPEP-00749

APA

López, José; Martínez, Alfredo. (2002). Cell and molecular biology of the multifunctional peptide, adrenomedullin.. International review of cytology, 221, 1-92.

MLA

López, José, et al. "Cell and molecular biology of the multifunctional peptide, adrenomedullin.." International review of cytology, 2002.

RethinkPeptides

RethinkPeptides Research Database. "Cell and molecular biology of the multifunctional peptide, a..." RPEP-00749. Retrieved from https://rethinkpeptides.com/research/lopez-2002-cell-and-molecular-biology

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.